These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 26883499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
    Nielsen PB, Larsen TB, Skjøth F, Lip GY.
    JAMA Intern Med; 2017 Apr 01; 177(4):563-570. PubMed ID: 28241151
    [Abstract] [Full Text] [Related]

  • 3. All-cause and bleeding-related health care costs in warfarin-treated patients with atrial fibrillation.
    Ghate SR, Biskupiak J, Ye X, Kwong WJ, Brixner DI.
    J Manag Care Pharm; 2011 Nov 01; 17(9):672-84. PubMed ID: 22050392
    [Abstract] [Full Text] [Related]

  • 4. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
    Cotté FE, Chaize G, Kachaner I, Gaudin AF, Vainchtock A, Durand-Zaleski I.
    J Stroke Cerebrovasc Dis; 2014 Feb 01; 23(2):e73-83. PubMed ID: 24119623
    [Abstract] [Full Text] [Related]

  • 5. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry.
    Shiozawa M, Koga M, Inoue H, Yamashita T, Yasaka M, Suzuki S, Akao M, Atarashi H, Ikeda T, Okumura K, Koretsune Y, Shimizu W, Tsutsui H, Hirayama A, Nakahara J, Teramukai S, Kimura T, Morishima Y, Takita A, Yamaguchi T, Toyoda K.
    Int J Stroke; 2023 Oct 01; 18(8):986-995. PubMed ID: 37154598
    [Abstract] [Full Text] [Related]

  • 6. Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?
    Paciaroni M, Agnelli G.
    Thromb Haemost; 2014 Jan 01; 111(1):14-8. PubMed ID: 24258528
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY.
    Circulation; 2015 Aug 11; 132(6):517-25. PubMed ID: 26059010
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
    Mercaldi CJ, Ciarametaro M, Hahn B, Chalissery G, Reynolds MW, Sander SD, Samsa GP, Matchar DB.
    Stroke; 2011 Jan 11; 42(1):112-8. PubMed ID: 21148442
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.
    Brønnum Nielsen P, Larsen TB, Gorst-Rasmussen A, Skjøth F, Rasmussen LH, Lip GYH.
    Chest; 2015 Jun 11; 147(6):1651-1658. PubMed ID: 25412369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Dilemma of Resuming Antithrombotic Therapy After Intracranial Hemorrhage in Patients With Left Ventricular Assist Devices.
    Santos CD, Matos NL, Asleh R, Dawit S, Rabinstein AA, O'Carroll CB, Li Z, Freeman WD.
    Neurocrit Care; 2020 Jun 11; 32(3):822-827. PubMed ID: 31531758
    [Abstract] [Full Text] [Related]

  • 15. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
    Witt DM, Clark NP, Martinez K, Schroeder A, Garcia D, Crowther MA, Ageno W, Dentali F, Ye X, Hylek E, Delate T.
    Thromb Res; 2015 Nov 11; 136(5):1040-4. PubMed ID: 26454758
    [Abstract] [Full Text] [Related]

  • 16. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?
    Eckman MH, Wong LK, Soo YO, Lam W, Yang SR, Greenberg SM, Rosand J.
    Stroke; 2008 Dec 11; 39(12):3308-15. PubMed ID: 18845797
    [Abstract] [Full Text] [Related]

  • 17. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
    Casciano JP, Dotiwala ZJ, Martin BC, Kwong WJ.
    J Manag Care Pharm; 2013 May 11; 19(4):302-16. PubMed ID: 23627576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes.
    Witt DM, Delate T, Hylek EM, Clark NP, Crowther MA, Dentali F, Ageno W, Martinez KD, Garcia DA.
    Thromb Res; 2013 May 11; 132(6):770-5. PubMed ID: 24521790
    [Abstract] [Full Text] [Related]

  • 20. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.
    O'Brien CL, Gage BF.
    JAMA; 2005 Feb 09; 293(6):699-706. PubMed ID: 15701911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.